Literature DB >> 30805702

Real-time MRI for the dynamic assessment of fundoplication failure in patients with gastroesophageal reflux disease.

Ali Seif Amir Hosseini1, Johannes Uhlig2, Ulrike Streit2, Dirk Voit3, Annemarie Uhlig4, Volker Ellenrieder5, Michael Ghadimi6, Thilo Sprenger6, Alexander Beham6, Martin Uecker2,7, Jens Frahm3,7, Joachim Lotz2,7, Lorenz Biggemann2.   

Abstract

PURPOSE: To assess the diagnostic potential of dynamic real-time MRI for fundoplication failure in patients with persistent or recurrent GERD-like (gastroesophageal reflux disease) complaints.
MATERIAL AND METHODS: Twenty-two consecutive patients (male n = 11; female n = 11; median age 59 years) with recurrent or persistent GERD-like symptom after fundoplication were enrolled between 2015 and 2017. Median duration of GERD-like symptoms was 21 months. Real-time MRI (3 Tesla) was performed at 40 ms temporal resolution using undersampled radial fast low-angle shot acquisitions with nonlinear inverse image reconstruction. MRI movies dynamically visualized bolus transit of pineapple juice through the gastroesophageal junction, position of the fundoplication wrap and recurring hernia or reflux during Valsalva maneuver. MRI results were compared to endoscopic findings.
RESULTS: Real-time MRI was successfully completed in all patients without adverse events (average examination time 15 min). Morphological correlates for GERD-like symptoms were evident in 20 patients (90.1%) with gastric reflux in 19 cases. Nine patients (40.1%) had wrap disruption and recurrent gastric hernia. Wrap migration or telescoping hernia was detected in nine patients (40.1%). One patient presented with continued reflux despite intact fundoplication wrap. Esophageal dysmotility with delayed bolus passage was observed in one case. On endoscopy, gastric hernia or wrap disruption was diagnosed in seven cases, and esophagitis or Barret's metaplasia in nine cases.
CONCLUSION: Real-time MRI is a fast and safe modality for dynamic imaging after fundoplication, without radiation exposure or administration of gadolinium-based contrast media. In a relevant number of cases, real-time MRI reveals correlates for GERD-like symptoms. KEY POINTS: • Real-time MRI reliably visualizes the gastroesophageal junction after fundoplication surgery. • Patients with recurring GERD-like symptoms have a high rate of morphological failure patterns that can be identified by real-time MRI. • Dynamic assessment of gastroesophageal junction by real-time MRI is a perspective diagnostic tool for detection of fundoplication failure.

Entities:  

Keywords:  Fundoplication; Gastroesophageal reflux disease (GERD); Magnetic resonance imaging

Mesh:

Year:  2019        PMID: 30805702     DOI: 10.1007/s00330-019-06025-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  19 in total

1.  Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision.

Authors:  J G Hunter; C D Smith; G D Branum; J P Waring; T L Trus; M Cornwell; K Galloway
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

2.  [A simple operation for control of reflux esophagitis].

Authors:  R NISSEN
Journal:  Schweiz Med Wochenschr       Date:  1956-05-18

Review 3.  Epidemiology of gastro-oesophageal reflux disease: a systematic review.

Authors:  J Dent; H B El-Serag; M-A Wallander; S Johansson
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  When fundoplication fails: redo?

Authors:  C Daniel Smith; David A McClusky; Murad Abu Rajad; Andrew B Lederman; John G Hunter
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

5.  Laparoscopic Nissen fundoplication: preliminary report.

Authors:  B Dallemagne; J M Weerts; C Jehaes; S Markiewicz; R Lombard
Journal:  Surg Laparosc Endosc       Date:  1991-09

6.  Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate.

Authors:  M Hashemi; J H Peters; T R DeMeester; J E Huprich; M Quek; J A Hagen; P F Crookes; J Theisen; S R DeMeester; L F Sillin; C G Bremner
Journal:  J Am Coll Surg       Date:  2000-05       Impact factor: 6.113

7.  Post-fundoplication symptoms: the role for endoscopic assessment of fundoplication integrity.

Authors:  J Jailwala; B Massey; D Staff; R Shaker; W Hogan
Journal:  Gastrointest Endosc       Date:  2001-09       Impact factor: 9.427

8.  Laparoscopic Nissen fundoplication: five-year results and beyond.

Authors:  T Lafullarde; D I Watson; G G Jamieson; J C Myers; P A Game; P G Devitt
Journal:  Arch Surg       Date:  2001-02

9.  Secondary achalasia and other esophageal motility disorders after laparoscopic Nissen fundoplication for gastroesophageal reflux disease.

Authors:  Natasha E Wehrli; Marc S Levine; Stephen E Rubesin; David A Katzka; Igor Laufer
Journal:  AJR Am J Roentgenol       Date:  2007-12       Impact factor: 3.959

10.  Five-year comprehensive outcomes evaluation in 181 patients after laparoscopic Nissen fundoplication.

Authors:  Mehran Anvari; Christopher Allen
Journal:  J Am Coll Surg       Date:  2003-01       Impact factor: 6.113

View more
  3 in total

Review 1.  Real-Time Magnetic Resonance Imaging.

Authors:  Krishna S Nayak; Yongwan Lim; Adrienne E Campbell-Washburn; Jennifer Steeden
Journal:  J Magn Reson Imaging       Date:  2020-12-09       Impact factor: 4.813

2.  Assessment of esophagogastric junction morphology by dynamic real-time MRI: comparison of imaging features to high-resolution manometry.

Authors:  Lorenz Biggemann; Johannes Uhlig; Nina Gliem; Omar Al-Bourini; Edris Wedi; Volker Ellenrieder; Michael Ghadimi; Martin Uecker; Jens Frahm; Joachim Lotz; Ali Seif Amir Hosseini; Ulrike Streit
Journal:  Jpn J Radiol       Date:  2021-12-07       Impact factor: 2.374

3.  Performance of a new natural oral contrast agent (LumiVision®) in dynamic MR swallowing.

Authors:  Christiane Kulinna-Cosentini; Michael A Arnoldner; Wolfgang Schima; Ivan Kristo; Sebastian F Schoppmann; Michael Weber; Enrico P Cosentini
Journal:  Eur Radiol       Date:  2021-04-24       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.